MedPath

Clinical Significance of Urinary Liver-Type Fatty Acid Binding Protein in Type 2 Diabetic Nephropathy

Not Applicable
Conditions
Type 2 Diabetic Nephropathy
Registration Number
JPRN-UMIN000002483
Lead Sponsor
ephrology and Hypertension, Internal Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
150
Inclusion Criteria

Not provided

Exclusion Criteria

no history of liver disease, primary kidney disease, cancer, or collagen disease; the degree of hematuria not more severe than the degree of proteinuria; and no hemodialysis

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
progression to higher stage of diabetic nephropathy.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath